Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution

The collaboration aims to enhance patient experience and adherence for self-administered injectable treatments.

Apr. 8, 2026 at 9:32pm

Got story updates? Submit your updates here. ›

A highly detailed, glowing 3D illustration of a futuristic, illuminated medical device with intricate cybernetic components and pulsing neon lights, symbolizing the integration of digital technology and advanced drug delivery systems.The partnership between Aptar Digital Health and Enable Injections aims to enhance the patient experience and adherence for self-administered injectable treatments through a new connected digital solution.Crystal Lake Today

Aptar Digital Health, a division of Aptar Group, has announced a partnership with Enable Injections, a leading developer of wearable drug delivery systems, to create a companion digital solution for Enable's enFuse® on-body injector. The new digital platform will provide patients with real-time data, guidance, and support to improve the self-administration experience and treatment adherence.

Why it matters

This collaboration represents an important step in the growing trend of connected health technologies that aim to empower patients and enhance the delivery of complex injectable medications. By integrating digital tools with drug delivery devices, pharmaceutical companies and medical technology firms are seeking to improve patient outcomes and reduce the burden of self-administered treatments.

The details

The enFuse® companion digital solution will leverage Aptar's expertise in connected drug delivery devices to provide patients with features like real-time injection monitoring, adherence tracking, educational content, and remote support from healthcare providers. This integration of digital and physical technologies is designed to improve the overall patient experience and increase the likelihood of proper medication administration.

  • The partnership between Aptar Digital Health and Enable Injections was announced on April 8, 2026.

The players

Aptar Digital Health

A division of Aptar Group, a leading global supplier of a broad range of innovative packaging, dispensing, and sealing solutions.

Enable Injections

A developer of wearable drug delivery systems, including the enFuse® on-body injector.

Got photos? Submit your photos here. ›

What they’re saying

“We are excited to partner with Enable Injections to enhance the patient experience and improve adherence for self-administered injectable treatments.”

— John Belfance, President of Aptar Digital Health

“This collaboration with Aptar Digital Health will allow us to provide patients with a more comprehensive and supportive self-injection experience.”

— Michael D. Hooven, President and CEO of Enable Injections

What’s next

The enFuse® companion digital solution is expected to be launched in the coming months, providing patients with a more integrated and user-friendly experience for self-administered injectable treatments.

The takeaway

This partnership between Aptar Digital Health and Enable Injections highlights the growing importance of connected health technologies in improving patient outcomes and reducing the burden of complex medical treatments. By integrating digital tools with drug delivery devices, the companies aim to empower patients and enhance the overall self-administration experience.